Search
Memantine
go.drugbank.com/drugs/DB01043ApprovedInvestigationalIn December 2013, the G8 dementia summit concluded that dementia should be considered a global priority with the objective of developing a cure or a disease-modifying therapy by the year 2025 [L5953, F4366 … Initially approved by the FDA in 2013, memantine is an N-methyl-D-aspartate (NMDA) receptor antagonist used in the management of Alzheimer's Disease (AD).
Mixtures: MELANDA 5 MG + 10 MG + 15 MG + 20 MG BAŞLANGIÇ PAKETİ, MELANDA 5 MG + 10 MG + 15 MG + 20 MG BAŞLANGIÇ PAKETİProducts: MEMANTINE HYDROCHLORIDE OD TABLETS 5 MG MEIJI, MEMANTINE HYDROCHLORIDE OD TABLETS 10 MG MEIJIIbandronate
go.drugbank.com/drugs/DB00710ApprovedInvestigational[A203138] Ibandronate was granted FDA approval on 16 May 2003.[L13805] … Ibandronate, or BM 21.0955, is a third generation, nitrogen containing bisphosphonate similar to [zoledronic acid], [minodronic acid], and [risedronic acid].
Mixtures: IBAMIN D3 150 MG/2800 IU FİLM KAPLI TABLET, 3 ADET, İBAMIN D3 150 MG/2800 IU GRANÜL İÇEREN SAŞE ,3 SAŞECategories: Drugs for Treatment of Bone DiseasesCarboplatin
go.drugbank.com/drugs/DB00958ApprovedInvestigationalCarboplatin is an organoplatinum antineoplastic alkylating agent used in the treatment of advanced ovarian carcinoma.[L32253] Early clinical studies of carboplatin were performed in 1982. … [A230523] Carboplatin was developed as an analog of [cisplatin] with reduced nephrotoxicity and vomiting.[A230463,A230523] Carboplatin was granted FDA approval on 3 March 1989.[L32248]
Categories: Compounds used in a research, industrial, or household settingProducts: CARBOPLATINO SUN, LILCARLIL® 10 MG/ML (150 MG/15ML)Omeprazole
go.drugbank.com/drugs/DB00338ApprovedInvestigationalVet approvedThese disorders may include gastroesophageal reflux disease (GERD), peptic ulcer disease, and other diseases characterized by the oversecretion of gastric acid. … This drug was the first clinical useful drug in its class, and its approval was followed by the formulation of many other proton pump inhibitor drugs [A174232].
Mixtures: OMEPRAZOL 20 MG, OMEPRAZOL 20 MGProducts: OMEPRAZOLO SUN, NANSENEntecavir
go.drugbank.com/drugs/DB00442ApprovedInvestigationalEntecavir is an oral antiviral drug used in the treatment of hepatitis B infection. It is marketed under the trade name Baraclude (BMS).
Products: ENTECAVIR SUN, TABLET 0.5 mgPitolisant
go.drugbank.com/drugs/DB11642ApprovedInvestigational[A32024] The therapeutic effectiveness of pitolisant was comparable to that of [modafinil]. … Pitolisant is a selective antagonist or inverse agonist of the histamine H3 receptor used to treat type 1 or 2 narcolepsy.
Loratadine
go.drugbank.com/drugs/DB00455ApprovedInvestigational[A176435] A lack of sedative and CNS adverse effects make loratadine, along with other second generation antihistamines, preferable over their 1st generation counterparts in many clinical situations. … Loratadine is a second generation antihistamine used to manage symptoms of allergic rhinitis.
Mixtures: DESENFRIOL-ON GRAGEAS REPETABS, Clarinase 5 mg/ 120 mg RetardtablettenProducts: Loratadine OD, LORATADINA EGMagnesium carbonate
go.drugbank.com/drugs/DB09481ApprovedMagnesium carbonate, also known as magnesite, is a common over the counter remedy for heartburn and upset stomach caused by overproduction of acid in the stomach [FDA Label].
Mixtures: GASTOPAL DUO 600 MG+70 MG+150 MG/5 ML SÜSPANSİYON, 100 ML, GASTREN DUO 600 MG+70 MG+150 MG/ 5ML SÜSPANSİYON, 100 MLCategories: Drugs for Treatment of Hyperkalemia and Hyperphosphatemia, Compounds used in a research, industrial, or household settingCholine alfoscerate
go.drugbank.com/drugs/DB04660Investigational(From Stedman, 26th ed) It counteracts the effects of urea on enzymes and other macromolecules. [PubChem] … A component of phosphatidylcholines (lecithins), in which the two hydroxy groups of glycerol are esterified with fatty acids.
Synonyms: sn-3-GPC, sn-Glycero-3-phosphocholineProducts: MEDOTİLİN 1000 MG/ 4 ML IM/IV ENJEKSİYONLUK ÇÖZELTİ İÇEREN AMPÜL, 3 ADETBuprenorphine
go.drugbank.com/drugs/DB00921ApprovedIllicitInvestigationalVet approvedBuprenorphine may also be a preferred agent over [methadone] (which is also commonly used to treat severe pain and opioid use disorder), as it has less effect on Qtc interval prolongation,[A186271,A186274 … Buprenorphine has a number of unique pharmacokinetic and pharmacodynamic properties that make it a preferred agent for the treatment of conditions requiring high doses of strong opioids.
Mixtures: Suboxone 8 mg/2 mg sublingual tablets, Suboxone 2 mg/0.5 mg sublingual tabletsCategories: Heterocyclic Compounds with 4 or More Rings, Serotonergic Drugs Shown to Increase Risk of Serotonin Syndrome